Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 24, Number 12—December 2018

Research Letter

Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary

Figures

Article Metrics

Elke Wollants1Comments to Author , David Smolders1, Reinout Naesens, Peggy Bruynseels, Katrien Lagrou, Jelle Matthijnssens, and Marc Van Ranst
Author affiliations: KU Leuven Rega Institute, Rega Institute, Leuven, Belgium (E. Wollants, J. Matthijnssens, M. Van Ranst); ZNA Hospital Middelheim, Antwerp, Belgium (D. Smolders, R. Naesens, P. Bruynseels); University Hospital Leuven, Leuven, Belgium (K. Lagrou, M. Van Ranst)

Cite This Article

Close

Highlight and copy the desired format.

EID Wollants E, Smolders D, Naesens R, Bruynseels P, Lagrou K, Matthijnssens J, et al. Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary. Emerg Infect Dis. 2018;24(12):2380-2382. https://dx.doi.org/10.3201/eid2412.180494
AMA Wollants E, Smolders D, Naesens R, et al. Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary. Emerging Infectious Diseases. 2018;24(12):2380-2382. doi:10.3201/eid2412.180494.
APA Wollants, E., Smolders, D., Naesens, R., Bruynseels, P., Lagrou, K., Matthijnssens, J....Van Ranst, M. (2018). Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary. Emerging Infectious Diseases, 24(12), 2380-2382. https://dx.doi.org/10.3201/eid2412.180494.

Abstract

An elderly patient in Belgium who became critically ill after returning from Hungary was tested for pathogens using routine diagnostic tests. All results were negative. However, using next-generation sequencing on a cultured respiratory sample, laboratorians detected a complete West Nile virus genome, similar to strains isolated in southeastern Europe.

West Nile virus (WNV) is a widespread reemerging global pathogen. Mosquito bites are the source for nearly all human infections. These infections usually remain asymptomatic; only 20%–40% of infected persons experience a mild influenza-like illness called West Nile fever. West Nile neuroinvasive disease, which can manifest as meningitis, encephalitis, or acute flaccid paralysis, develops in 1% of infected persons; immunosuppressed and elderly patients are at higher risk (1). WNV can be divided into 5 phylogenetic lineages, of which lineages 1 and 2 have been associated with many outbreaks in humans. Since 2010, occasional localized epidemics have been ongoing in European and Mediterranean countries (2). To date, no autochthonous WNV infections have been reported in Belgium, and imported cases are uncommon (3,4).

An 83-year-old man residing in Antwerp, Belgium, who had a medical history of moderate chronic kidney disease traveled to Hungary from January through August 2017. One day after returning from Hungary, he went to the hospital emergency department. He had fever and sought treatment for pain in his mouth and throat, which had begun the day before. He reported having felt unusually fatigued over several days. Clinical examination showed the patient to be lethargic but having no abnormal neurologic signs.

Laboratory testing at admission revealed a normal leukocyte count of 6.8 × 109 cells/L and a moderately elevated C-reactive protein level of 63.2 mg/L. A urine sediment test, a chest radiograph, and an abdominal ultrasound revealed no signs of disease. Treatment with amoxicillin/clavulanate was started, and blood and urine samples for cultures were collected. After 5 days, the patient was transferred to the intensive care unit because of increasing lethargy, followed by loss of consciousness, and clinical and biochemical signs of multiple organ failure. He was intubated and his treatment changed to piperacillin/tazobactam and clarithromycin; new cultures were also performed. Fever persisted, and the patient developed pancytopenia (leukocytes 1.68 × 109 cells/L; hemoglobin 8.6 g/dL; platelets 61 × 109/L). Because kidney function deteriorated further, continuous venovenous ultrafiltration hemodialysis was begun. An electroencephalogram exam showed delayed response without signs of epilepsy. A cranial computed tomography scan showed no signs of acute disease, and autoimmune screening did not reveal any abnormalities.

The results from a multiplex PCR (RespiFinder22; PathoFinder, Maastricht, the Netherlands), performed on a broncheoalveolar lavage (BAL) sample, were negative for 22 different respiratory pathogens. The result from a singleplex PCR for Mycobacterium tuberculosis was negative. Test results from immunofluorescence and PCR for Pneumocystis jirovecii were also negative. Cerebrospinal fluid testing revealed an elevated pH of 7.95, elevated total protein of 79 mg/dL, normal glucose of 65 mg/dL, slightly increased leukocytosis of 7/mm3, and elevated erythrocytes of 370/mm3. Results were negative for molecular diagnostics of cerebrospinal fluid for 13 pathogens and serology testing for 12 pathogens. Results from viral cultures on a BAL sample, taken 8 days after hospital admission, showed a cytopathogenic effect on 3 available cell lines (Vero, HEp-2, and MRC5) 7 days after incubation. Results from a PCR, administered in an effort to identify the positive viral culture, for herpes simplex virus and enterovirus were both negative.

Because the general condition of the patient had improved and stabilized, he was weaned from intubation 14 days after admission to the intensive care unit. He was discharged to the geriatric department and slowly recovered consciousness; his neurologic status also normalized. Three months after onset of the infection, the patient described having some memory loss and no memory at all of the days when the infection first started.

Because routine testing did not lead to a diagnosis, a BAL sample and a viral culture were sent to the University Hospital Leuven (Leuven, Belgium). The cell culture was subjected to next-generation sequencing (NGS) with the novel enrichment technique of VIRomes protocol (5). This protocol includes purification of viral particles, nucleic acid extraction, and random PCR amplification, followed by library preparation and sequencing using NextSeq 500 system NGS technology (Illumina, San Diego, CA, USA) (6). The sequence reads obtained were filtered and trimmed, de novo assembled, and taxonomically classified (7,8). Analysis of the NGS results identified a complete West Nile virus genome (11,060 nt). To confirm this result, a novel RNA extraction and a reverse transcription PCR (QIAGEN, Venlo, the Netherlands) with newly developed primers were performed on the BAL sample and cell culture, followed by Sanger sequencing (9). The sequence obtained from the positive sample was identical to the sequence from the complete genome obtained by NGS.

Figure

Thumbnail of Alignments of complete WNV genome identified from patient in Belgium compared with 32 known reference strains from the 5 established WNV lineages. A phylogenetic tree was constructed using the maximum-likelihood method based on the Tamura-Nei model. Evolutionary analyses were conducted in MEGA7 (http://www.megasoftware.net). Bootstrapping was conducted with 1,000 bootstrap replicates; only bootstraps values over 70% are shown. The phylogenetic tree clusters the strain from this pati

Figure. Alignments of complete WNV genome identified from patient in Belgium compared with 32 known reference strains from the 5 established WNV lineages. A phylogenetic tree was constructed using the maximum-likelihood method...

The WNV lineage 2 strain in this study, WNV-2|Belgium|2017|Antwerp (GenBank accession number: MH021189), is closely related (99.4%–99.6% nucleotide similarity) to a strain from Hungary and other Balkan countries identified between 2010 and 2015 (Figure), reinforcing the conclusion that this WNV infection was acquired in Hungary. This case illustrates that the combined use of cell cultures and NGS can be a powerful tool for identifying unknown pathogens in clinical specimens when results from routine tests are negative and the patient’s condition is undiagnosed.

Elke Wollants currently works as laboratory manager in the Clinical Virology Lab at the Rega Institute, KU Leuven. Her research interests are identifying pathogens not detected in routine diagnostic laboratory tests and next-generation sequencing.

Top

References

  1. Rizzoli  A, Jimenez-Clavero  MA, Barzon  L, Cordioli  P, Figuerola  J, Koraka  P, et al. The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surv. 2015;20(20).
  2. Petersen  LR, Brault  AC, Nasci  RS. West Nile virus: review of the literature. JAMA. 2013;310:30815. DOIPubMed
  3. Cnops  L, Papa  A, Lagra  F, Weyers  P, Meersman  K, Patsouros  N, et al. West Nile virus infection in Belgian traveler returning from Greece. Emerg Infect Dis. 2013;19:6845. DOIPubMed
  4. VAN DEN Bossche  D, Cnops  L, Meersman  K, Domingo  C, VAN Gompel  A, VAN Esbroeck  M. Chikungunya virus and West Nile virus infections imported into Belgium, 2007-2012. Epidemiol Infect. 2015;143:222736. DOIPubMed
  5. Conceição-Neto  N, Zeller  M, Lefrère  H, De Bruyn  P, Beller  L, Deboutte  W, et al. Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis. Sci Rep. 2015;5:16532. DOIPubMed
  6. Conceição-Neto  N, Zeller  M, Lefrère  H, De Bruyn  P, Beller  L, Deboutte  W, et al. NetoVIR: a reproducible protocol for virome analysis. London: Nature Publishing Group; 2016.
  7. Bankevich  A, Nurk  S, Antipov  D, Gurevich  AA, Dvorkin  M, Kulikov  AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–77.
  8. Buchfink  B, Xie  C, Huson  DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 2015;12:5960. DOIPubMed
  9. Wollants  E, De Coster  S, Van Ranst  M, Maes  P. A decade of norovirus genetic diversity in Belgium. Infect Genet Evol. 2015;30:37–44.

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2412.180494

Original Publication Date: 11/7/2018

1These authors contributed equally to this article.

Table of Contents – Volume 24, Number 12—December 2018

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Elke Wollants, Rega Institute, KU Leuven, Laboratory of Clinical Virology, Herestraat 49 Box 1040 Leuven 3000, Belgium


character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

TOP